Trials / Unknown
UnknownNCT04934605
Genotype-phenotype Correlation of SLC26A4 in CI Patients With EVA
A Genotype-phenotype Correlation of SLC26A4 Mutations in Cochlear-implanted Patients With Enlarged Vestibular Aqueduct
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
- Sex
- All
- Age
- 0 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
To explore the genotype-phenotype correlation of SLC26A4 mutations in cochlear-implanted patients with enlarged vestibular aqueduct.
Detailed description
Enlarged vestibular aqueduct (EVA) is one of the most common forms of inner ear malformation that cause sensorineural hearing loss (SNHL). Some patients with EVA present delayed, fluctuating, and progressive hearing loss, while the others are with congenital or sudden hearing loss. Cochlear implants (CI) have been widely used in patients with severe-profound SNHL. However, it is difficult to define the optimal timing of CI operations for patients with EVA. Mutations in SLC26A4 are known to be responsible for EVA. This study is to explore the genotype-phenotype correlation of SLC26A4 mutations in cochlear-implanted patients with EVA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Cochlear implantation | Cochlear implantation |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2021-05-01
- Completion
- 2021-07-01
- First posted
- 2021-06-22
- Last updated
- 2021-06-22
Source: ClinicalTrials.gov record NCT04934605. Inclusion in this directory is not an endorsement.